F/m Emerald Life Sciences Innovation ETFF/m Emerald Life Sciences Innovation ETFF/m Emerald Life Sciences Innovation ETF

F/m Emerald Life Sciences Innovation ETF

No trades

Fund composition


As of May 13, 2026
Symbol
Weight %
Shares
Market value
C
COGTCogent Biosciences, Inc.
7.51%
‪‪226.14 K‬‬
‪‪7.75 M‬‬USD
T
TVTXTravere Therapeutics, Inc.
7.37%
‪‪170.71 K‬‬
‪‪7.61 M‬‬USD
L
LIVNLivaNova Plc
7.10%
‪‪101.21 K‬‬
‪‪7.33 M‬‬USD
S
SYRESpyre Therapeutics, Inc
6.77%
‪‪91.59 K‬‬
‪‪6.99 M‬‬USD
M
MIRMMirum Pharmaceuticals, Inc.
5.38%
‪‪50.91 K‬‬
‪‪5.56 M‬‬USD
U
UTHRUnited Therapeutics Corporation
4.40%
‪‪7.84 K‬‬
‪‪4.54 M‬‬USD
G
GHGuardant Health, Inc.
4.26%
‪‪44.69 K‬‬
‪‪4.40 M‬‬USD
N
NKTRNektar Therapeutics
3.74%
‪‪50.88 K‬‬
‪‪3.86 M‬‬USD
M
MANEVeradermics, Incorporated
3.69%
‪‪35.57 K‬‬
‪‪3.81 M‬‬USD
T
TRVITrevi Therapeutics, Inc.
3.43%
‪‪231.60 K‬‬
‪‪3.54 M‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.